Results 241 to 250 of about 6,918,961 (308)

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein, Maximilian Mönch, Meret Herdick, Frauke Stascheit, Sarah Hoffmann, Hannah Preßler, Philipp Mergenthaler, Carla Dusemund, Paolo Doksani, Haoqi Sun, Pushpa Narayanaswami, Andreas Meisel, Lea Gerischer, Sophie Lehnerer   +13 more
wiley   +1 more source

Evaluating quality of care for dying patients from the perspective of bereaved relatives: validation of the Chinese version of the international care of the dying evaluation. [PDF]

Health Qual Life Outcomes
Zheng X, Zhou L, Li B, Dong L, Li Y, Mayland CR, Aoyama M, Miyashita M.   +7 more
europepmc   +1 more source

Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epidemiologic studies have reported inconsistent altered cancer risk in individuals with multiple sclerosis (MS). Factors such as immune dysregulation, comorbidities, and disease‐modifying therapies may contribute to this variability.
Asli Buyukkurt, Marius Ygonia, Ali Manouchehrinia, Philippe Lefrançois, Ingrid Kockum, Adil Harroud   +5 more
wiley   +1 more source

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

European Code Against Cancer, 5th edition - a tool for enhancing cancer prevention. [PDF]

Mol Oncol
Schüz J, Espina C, Weiderpass E, Nagy P.   +3 more
europepmc   +1 more source

Attribute knowledge and KBGAT for predicting the accuracy of the harmonized system code for classifying import and export commodities. [PDF]

Sci Rep
Qi L, Zhang Q, Lin X, Zhang J, Liao M.
europepmc   +1 more source

Computational modelling identifies key determinants of subregion-specific dopamine dynamics in the striatum. [PDF]

Elife
Ejdrup A, Dreyer JK, Lycas MD, Jørgensen SH, Robbins TW, Dalley J, Herborg F, Gether U.   +7 more
europepmc   +1 more source

The rationale for removing typification from virus taxonomy. [PDF]

Arch Virol
Siddell SG.
europepmc   +1 more source

Commercial Price Variation for 11 Outpatient-Based Psychiatric Services.

JAMA Netw Open
King K, Skydel JJ, Ross JS, Wallach JD.
europepmc   +1 more source

Correction to "Evaluating linked ICD-10 Medicare claims data as a method of dementia case ascertainment in research settings". [PDF]

Alzheimers Dement
europepmc   +1 more source